Compare Global X Cloud Computing ETF (CLOU) vs Neurocrine Biosciences Inc (NBIX) Price & Performance

Global X Cloud Computing ETFTrade

Neurocrine Biosciences IncTrade

Price performance (Past 24H)

Key statistics

Global X Cloud Computing ETF vs Neurocrine Biosciences Inc — how do they compare? Global X Cloud Computing ETF trades at $27.72, while Neurocrine Biosciences Inc trades at $152.5 (market cap $16.46B). The key difference: Global X Cloud Computing ETF is trading nearer its 52-week high, Neurocrine Biosciences Inc nearer its low. Which is the better fit depends on your goals.

	CLOU	NBIX
Sector	Sector/Thematic	Health
52-Week High	$28.09	$185.50
52-Week Low	$17.60	$123.10
Market Cap	—	$16.46B
Enterprise Value	—	$16.48B

View details →View details →

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

CLOU

Global X Cloud Computing ETF (CLOU) rated buy for strong growth beyond AI and resilient revenue streamsSeeking Alpha · 2 days agoBullish View details →

NBIX

INGREZZA shows significant quality of life and movement improvements in tardive dyskinesia patients after 24 weeks.PRNewsWire · 4 hours agoBullish View details →

About Global X Cloud Computing ETF

CLOU is a thematic ETF that invests in companies leading the cloud revolution. It targets providers of SaaS, PaaS, and IaaS, including major firms like Salesforce, Akamai, and Shopify that drive modern digital infrastructure.

About Neurocrine Biosciences Inc

Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative treatments for neurological, endocrine, and psychiatric disorders. The company's portfolio targets conditions such as tardive dyskinesia, endometriosis, and Parkinson's disease. NBIX leverages its expertise in neurobiology and small-molecule drug development to address diseases with significant unmet medical needs.